Oncolys BioPharma Inc. (4588.T) JPX
Currency In JPY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 35.6B |
| Enterprise Value | 32.25B |
| P/E Ratio | -61.5 |
| PEG Ratio | -1.1 |
| Price/Sales Ratio | 196.74 |
| Price/Book Ratio | 30.4 |
| Enterprise/Revenue | 192.48 |
| Enterprise/EBITDA | -64.27 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -3 |
| Operating Margin | -3.03 |
AD
Management Effectiveness
| Return On Assets | -0.33 |
| Return On Equity | -0.48 |
Income Statement
| Revenue | 28.55M |
| Revenue/Share | 17.17 |
| Gross Profit | 28.3M |
| EBITDA | -2.05B |
| Net Income | -2.06B |
| Diluted EPS | -80 |
Balance Sheet
| Total Cash | 3.19B |
| Total Cash/Share | 108.79 |
| Total Debt | 799.33M |
| Total Debt/Equity | 0.25 |
| Current Ratio | 3.91 |
| Book Value Per Share | 111.2 |
Price History
| 52-Week Change | 374.72 |
| 52-Week High | 3,785 |
| 52-Week Low | 601 |
| Moving Average 50 Days | 2,747.84 |
| Moving Average 200 Days | 2,219.34 |
Statistics
| Average Volume | 1.15M |
| Shares Outstanding | 29.28M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
